Intra Cellular Therapies | L'Utile Operativo

Operating Profit Cambiamento Data
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
ALKERMES USD 43.85M 195.34M 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Cytokinetics USD -127418000 5.15M 2023-12
Gilead Sciences USD 1.61B 1.01B 2023-12
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Intra Cellular Therapies USD -34097000 4.38M 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
RedHill Biopharma USD -4408000 33.49M 2023-06
Supernus Pharmaceuticals USD -996000 9.13M 2023-12
United Therapeutics USD 260.1M 66.9M 2023-12



Intra Cellular Therapies L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.